Citigroup
GDRX icon

Citigroup’s GoodRx Holdings GDRX Stock Holding History

Citigroup’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,000
Closed -$40K – 6669
2020
Q4 		$40K Buy
+1,000
New +$45.9K ﹤0.01% 6196

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Citigroup's GDRX Position: Q1 2026 in Review

Citigroup increased its GoodRx Holdings (GDRX) stake by 90% in Q1 2026, buying an estimated $22.5K and bringing the position to 20,207 shares worth $39.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4615.

Citigroup first reported a position in GDRX in Q4 2020 and has held it in 18 quarters since. The position peaked at $5.3M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Citigroup held 20,207 shares of GoodRx Holdings worth $39.6K as of Q1 2026.
  • Citigroup bought 9,592 GoodRx Holdings shares in Q1 2026, an estimated $22.5K.
  • GoodRx Holdings made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4615 holding.
  • Citigroup first reported a position in GoodRx Holdings in Q4 2020 and has held it in 18 quarters since.
  • Citigroup's GoodRx Holdings position peaked at $5.3M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.